NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
763.20
Change Change %
22.75 3.07%

Updated:05 Feb, 2016, 15:58 PM IST

BSE
762.55
Change Change %
21.75 2.94%

Updated:05 Feb, 2016, 15:58 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

715.10 768.00

52 Wk Range

465.00 891.50
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

715.05767.65

52 Wk Range

490.50 891.50

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Bank of America Merrill Lynch
-
03-02-2016 Buy 771.80 1050.00 Open Details
Citi
-
12-10-2015 Buy 793.05 1120.00 Open Details
Citi
-
28-08-2015 Buy 743.90 1120.00 Open Details
Citi
-
19-03-2015 Buy 1262.10 1945.00 Open Details
Bank of America Merrill Lynch
-
20-02-2015 Buy 1038.05 1430.00 Target Hit Details

More from Research Reports »

Aurobindo Pharma's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 44,633.46
Earning Per Share (EPS TTM) (₹) 44.80
Price To Earnings (P/E) Ratio 17.04
Book Value Per Share (₹) 183.55
Price To Books (P/B) Ratio 4.16
EBIT Margin (%) 25.14
PAT Margin (%) 18.39
ROCE (%) 26.60
PAT Growth (%) 29.37
Total Debt to Equity (D/E) Ratio 0.61

More from Key Fundamentals »

Aurobindo Pharma's Financial Summary

Parameter MAR'15
(₹ Cr.)
MAR'14
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 29.20 29.15 0.17%
Total Non-Current Liabilities 920.15 1,245.86 -26.14%
Total Current Liabilities 3,946.19 3,317.28 18.96%
Total Liabilities 10,225.88 8,575.53 19.24%
Total Non-Current Assets 3,857.80 3,494.35 10.40%
Currents Investments 19.64 0.03 65366.67%
Cash and Bank 11.13 9.72 14.51%
Total Current Assets Excluding Current Investments 6,348.44 5,081.15 24.94%
Total Assets 10,225.88 8,575.53 19.24%
Profit and Loss:
Gross Sales 8,244.84 7,269.53 13.42%
Net Sales 8,095.10 7,110.71 13.84%
PBIDT (Excl OI) 2,250.42 1,919.47 17.24%
PAT 1,516.35 1,172.09 29.37%

More from Financial Summary �

Aurobindo Pharma's Shareholding Pattern

's Futures and Options Quotes

Contract
Expiry Date
Type Current price Change Change % Premium / Discount
AUROPHARMA
25-02-2016
FUTSTK
734.00 -7.65 -1.03% -29.20
AUROPHARMA
31-03-2016
FUTSTK
735.00 -10.40 -1.40% -28.20
AUROPHARMA
28-04-2016
FUTSTK
730.00 -2.15 -0.29% -33.20

More from Futures and Options Quotes »

Post your comments about Aurobindo Pharma